Osaic Holdings Inc. boosted its holdings in shares of Counterpoint Quantitative Equity ETF (NYSEARCA:CPAI – Free Report) by 1,862.2% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 107,330 shares of the company’s stock after buying an additional 101,860 shares during the period. Osaic Holdings Inc. owned approximately 3.99% of Counterpoint Quantitative Equity ETF worth $3,991,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors have also recently bought and sold shares of the business. Raymond James Financial Inc. purchased a new position in Counterpoint Quantitative Equity ETF during the 2nd quarter valued at about $1,121,000. Steward Partners Investment Advisory LLC boosted its holdings in shares of Counterpoint Quantitative Equity ETF by 102.9% during the second quarter. Steward Partners Investment Advisory LLC now owns 68,061 shares of the company’s stock worth $2,531,000 after purchasing an additional 34,518 shares during the period. JPMorgan Chase & Co. grew its position in Counterpoint Quantitative Equity ETF by 4.9% during the second quarter. JPMorgan Chase & Co. now owns 6,130 shares of the company’s stock valued at $228,000 after purchasing an additional 286 shares in the last quarter. Avantax Advisory Services Inc. grew its position in Counterpoint Quantitative Equity ETF by 27.7% during the second quarter. Avantax Advisory Services Inc. now owns 56,600 shares of the company’s stock valued at $2,105,000 after purchasing an additional 12,266 shares in the last quarter. Finally, Concurrent Investment Advisors LLC acquired a new position in Counterpoint Quantitative Equity ETF in the 2nd quarter valued at approximately $1,700,000.
Counterpoint Quantitative Equity ETF Stock Up 0.4%
CPAI stock opened at $40.64 on Thursday. The company has a 50 day moving average of $39.65 and a two-hundred day moving average of $37.95. The company has a market cap of $130.05 million, a price-to-earnings ratio of -48,729.02 and a beta of 1.25. Counterpoint Quantitative Equity ETF has a 12-month low of $28.48 and a 12-month high of $41.36.
Counterpoint Quantitative Equity ETF Announces Dividend
Counterpoint Quantitative Equity ETF Company Profile
The Counterpoint Quantitative Equity ETF (CPAI) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed, seeking long-term capital appreciation through a quantitative, model-based approach to select US stocks of any market capitalization. CPAI was launched on Nov 28, 2023 and is issued by Counterpoint.
Read More
- Five stocks we like better than Counterpoint Quantitative Equity ETF
- Do not delete, read immediately
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Can Any Expenses Be Deducted From Capital Gains Tax?
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Forget AI, This Will Be the Next Big Tech Breakthrough
Receive News & Ratings for Counterpoint Quantitative Equity ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Counterpoint Quantitative Equity ETF and related companies with MarketBeat.com's FREE daily email newsletter.
